Pharma
-
Nipocalimab shows stronger responses in Sjögren’s disease patients with high autoantibody levels
New Phase 2 analyses presented by Johnson & Johnson suggest that adults with moderate-to-severe Sjögren’s disease and elevated disease-driving autoantibodies…
Read More » -
Serum Institute to manufacture Oxford’s Ebola vaccine
The Coalition for Epidemic Preparedness Innovations (CEPI) has moved to accelerate the development of three investigational vaccines against Bundibugyo ebolavirus,…
Read More » -
Ayush export push gets spice sector backing
India’s push to expand its global wellness footprint received a fresh boost after AYUSHEXCIL and the Spices Board of India…
Read More » -
EU moves to secure medicine supply with Critical Medicines Act
The European Commission, the European Parliament and the Council of the European Union have reached a political agreement on the…
Read More » -
Sun Pharma to acquire Organon in $11.75 billion deal
Sun Pharmaceutical Industries Ltd. has signed a definitive agreement to acquire Organon & Co. in an all-cash transaction valued at…
Read More » -
FDA nod to Roche’s lupus drug Gazyva marks potential shift in treatment landscape
The United States Food and Drug Administration has accepted Roche’s application for Gazyva, also known as Gazyvaro, for the treatment…
Read More » -
CARI Bengaluru sets quality benchmark in Ayush diagnostics
The Clinical Laboratory at the Central Ayurveda Research Institute in Bengaluru has received ISO 15189:2022 accreditation for Biochemistry and Haematology,…
Read More » -
Singapore becomes first country to achieve WHO’s highest rating for medical device regulation
Singapore has set a global benchmark in health regulation, becoming the first country to achieve the highest classification under the…
Read More »








